Linda Vidarsdóttir

Artiklar

Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(37):9942-9947

The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene.

Lister N; Shevchenko G; Walshe JL; Groen J; Johnsson P; Vidarsdóttir L; Grander D; Ataide SF; Morris KV
Article: NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2013;20(4):440-446

A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells.

Johnsson P; Ackley A; Vidarsdottir L; Lui W-O; Corcoran M; Grandér D; Morris KV
Article: INVESTIGATIONAL NEW DRUGS. 2012;30(2):425-434

Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition.

Vidarsdottir L; Steingrimsdottir G; Bodvarsdottir SK; Ogmundsdottir HM; Eyfjord JE
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2007;99(12):929-935

Prostate cancer progression and survival in BRCA2 mutation carriers.

Tryggvadóttir L; Vidarsdóttir L; Thorgeirsson T; Jonasson JG; Olafsdóttir EJ; Olafsdóttir GH; Rafnar T; Thorlacius S; Jonsson E; Eyfjord JE; Tulinius H
Article: CANCER LETTERS. 2007;250(2):206-212

Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutations.

Vidarsdottir L; Bodvarsdottir SK; Hilmarsdottir H; Tryggvadottir L; Eyfjord JE

Review: ONCOGENE. 2019;38(1):1-16

Polo-like kinases and acute leukemia.

Goroshchuk O; Kolosenko I; Vidarsdottir L; Azimi A; Palm-Apergi C
KI thesis / dissertation: 2017

Functional analysis of long non-coding RNAs in cancer

Vidarsdottir, Linda
Editorial comment: EUROPEAN UROLOGY. 2007;52(5):1529

Re: Prostate cancer progression and survival in BRCA2 mutation carriers.

Boormans JL; Schröder FH
Letter: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2007;16(11):2517

AURKA and breast cancer in BRCA1/2 mutation carriers.

Bodvarsdottir SK; Vidarsdottir L; Eyfjord JE